US Edition
PI-RADS v2.1 Plus Amide Transfer Boosts Detection
Summary by BIOENGINEER.ORG
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
PI-RADS v2.1 Plus Amide Transfer Boosts Detection
In a groundbreaking advancement for prostate cancer diagnostics, recent research published in BMC Cancer unveils how combining amide proton transfer (APT) magnetic resonance imaging (MRI) metrics with the widely adopted PI-RADS version 2.1 scoring system significantly enhances the detection of clinically significant prostate cancer (csPCa). This study, conducted by Zhang, Li, Zhe, and colleagues, highlights […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium